This inventor holds 2 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignee: Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Zhoushan Tian: Innovator in Pharmaceutical Development
Introduction
Zhoushan Tian is a notable inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific protein kinases. His work has implications for the prevention and treatment of various diseases.
Latest Patents
Zhoushan Tian holds 1 patent for an AKT inhibitor. This invention specifically relates to a compound represented by formula I or a pharmaceutically acceptable salt thereof. The patent also outlines a preparation method and the use of the compound in the prevention and/or treatment of diseases mediated by AKT protein kinase.
Career Highlights
Throughout his career, Zhoushan Tian has worked with Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. This experience has allowed him to apply his innovative ideas in a practical setting, contributing to advancements in pharmaceutical research and development.
Collaborations
Zhoushan Tian has collaborated with notable colleagues, including Donghui Chen and Dan Xu. Their combined expertise has fostered a productive environment for innovation in the pharmaceutical industry.
Conclusion
Zhoushan Tian's contributions to the field of pharmaceuticals, particularly through his patent for an AKT inhibitor, highlight his role as an innovator. His work continues to influence the development of treatments for diseases mediated by AKT protein kinase.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile